Article: Increased expression of survivin in gastric cancer patients and in first degree relatives

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleIncreased expression of survivin in gastric cancer patients and in first degree relatives
AuthorsYu, J1
Leung, WK1
Ebert, MPA1
Ng, EKW1
Go, MYY1
Wang, HB1
Chung, SCS1
Malfertheiner, P1
Sung, JJY1
Issue Date2002
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/bjc
CitationBritish Journal Of Cancer, 2002, v. 87 n. 1, p. 91-97 [How to Cite?]
DOI: http://dx.doi.org/10.1038/sj.bjc.6600421
AbstractSurvivin was recently described as an apoptosis inhibitor. Its pathogenic role in gastric cancer is largely unknown. Expression of survivin in gastric cancer and non-cancer first-degree relatives, and its association with apoptosis and cyclo-oxygenase-2 expression was investigated. Fifty gastric cancer, 30 non-cancer first-degree relatives, 20 normal controls and five gastric cancer cell lines were studied. Survivin and cyclo-oxygenase-2 were evaluated by reverse transcriptase-polymerase chain reaction, immunohistochemistry and Western blot. Survivin expression was absent from normal gastric mucosa. All five cancer cell lines and 34 out of 50 (68%) human gastric cancer tissues expressed survivin mRNA. Survivin expression was less frequent (22%; P<0.001) in adjacent non-tumour gastric tissues. Immunohistochemistry and Western blot obtained similar findings. Gastric cancers with survivin expression displayed significantly reduced apoptosis (P=0.02), and associated with cyclo-oxygenase-2 overexpression at both mRNA (P=0.001) and protein levels (P=0.041). Moreover, survivin mRNA was detected in the gastric mucosa of eight (27%) non-cancer relatives. Expression in non-cancer patients showed positive correlation with H. pylori infection (P=0.004). This demonstrates the frequent expression of survivin in gastric cancer and in first-degree relatives. Co-expression of survivin and cyclo-oxygenase-2 may suggest multiple pathways contributing to the inhibition of apoptosis in gastric cancer. © 2002 Cancer Research UK.
ISSN0007-0920
2011 Impact Factor: 5.042
2011 SCImago Journal Rankings: 0.561
DOIhttp://dx.doi.org/10.1038/sj.bjc.6600421
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorYu, J
dc.contributor.authorLeung, WK
dc.contributor.authorEbert, MPA
dc.contributor.authorNg, EKW
dc.contributor.authorGo, MYY
dc.contributor.authorWang, HB
dc.contributor.authorChung, SCS
dc.contributor.authorMalfertheiner, P
dc.contributor.authorSung, JJY
dc.date.accessioned2012-09-05T05:21:48Z
dc.date.available2012-09-05T05:21:48Z
dc.date.issued2002
dc.description.abstractSurvivin was recently described as an apoptosis inhibitor. Its pathogenic role in gastric cancer is largely unknown. Expression of survivin in gastric cancer and non-cancer first-degree relatives, and its association with apoptosis and cyclo-oxygenase-2 expression was investigated. Fifty gastric cancer, 30 non-cancer first-degree relatives, 20 normal controls and five gastric cancer cell lines were studied. Survivin and cyclo-oxygenase-2 were evaluated by reverse transcriptase-polymerase chain reaction, immunohistochemistry and Western blot. Survivin expression was absent from normal gastric mucosa. All five cancer cell lines and 34 out of 50 (68%) human gastric cancer tissues expressed survivin mRNA. Survivin expression was less frequent (22%; P<0.001) in adjacent non-tumour gastric tissues. Immunohistochemistry and Western blot obtained similar findings. Gastric cancers with survivin expression displayed significantly reduced apoptosis (P=0.02), and associated with cyclo-oxygenase-2 overexpression at both mRNA (P=0.001) and protein levels (P=0.041). Moreover, survivin mRNA was detected in the gastric mucosa of eight (27%) non-cancer relatives. Expression in non-cancer patients showed positive correlation with H. pylori infection (P=0.004). This demonstrates the frequent expression of survivin in gastric cancer and in first-degree relatives. Co-expression of survivin and cyclo-oxygenase-2 may suggest multiple pathways contributing to the inhibition of apoptosis in gastric cancer. © 2002 Cancer Research UK.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationBritish Journal Of Cancer, 2002, v. 87 n. 1, p. 91-97 [How to Cite?]
DOI: http://dx.doi.org/10.1038/sj.bjc.6600421
dc.identifier.doihttp://dx.doi.org/10.1038/sj.bjc.6600421
dc.identifier.epage97
dc.identifier.issn0007-0920
2011 Impact Factor: 5.042
2011 SCImago Journal Rankings: 0.561
dc.identifier.issue1
dc.identifier.pmid12085263
dc.identifier.scopuseid_2-s2.0-0036648414
dc.identifier.spage91
dc.identifier.urihttp://hdl.handle.net/10722/162624
dc.identifier.volume87
dc.languageeng
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/bjc
dc.publisher.placeUnited Kingdom
dc.relation.ispartofBritish Journal of Cancer
dc.relation.referencesReferences in Scopus
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 And Over
dc.subject.meshApoptosis
dc.subject.meshBlotting, Western
dc.subject.meshChromosomal Proteins, Non-Histone - Biosynthesis
dc.subject.meshCyclooxygenase 2
dc.subject.meshFemale
dc.subject.meshGene Expression Regulation, Neoplastic
dc.subject.meshGenetic Predisposition To Disease
dc.subject.meshHelicobacter Infections - Complications
dc.subject.meshHumans
dc.subject.meshImmunohistochemistry
dc.subject.meshInhibitor Of Apoptosis Proteins
dc.subject.meshIsoenzymes - Biosynthesis
dc.subject.meshMale
dc.subject.meshMembrane Proteins
dc.subject.meshMicrotubule-Associated Proteins
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Proteins
dc.subject.meshPedigree
dc.subject.meshProstaglandin-Endoperoxide Synthases - Biosynthesis
dc.subject.meshRna, Messenger - Analysis
dc.subject.meshStomach Neoplasms - Genetics - Physiopathology
dc.subject.meshTumor Cells, Cultured
dc.titleIncreased expression of survivin in gastric cancer patients and in first degree relatives
dc.typeArticle
Author Affiliations
  1. Prince of Wales Hospital Hong Kong